I am actually suggesting 30x CURRENT earnings (FY2021 NPAT around $4m) or around $100m MC.
This is from GC presentation a few months ago.
They are already beating their growth forecasts in 12 months with revenues growing 50% & EBITDA margin above 9%.( they were hoping for EBITDA margin "towards" 8% by 2025).....Could this big jump in EBITDA margin in 2H21 be an aberration?....Who knows.
"IF" they meet their 5 year ambitions , SEQ will have >$300m MC in 2025 with revenues $400m & EBITDA approaching $40m.
- Forums
- ASX - By Stock
- Ann: Trading Update and FY21 Guidance
SEQ
sequoia financial group ltd
Add to My Watchlist
0.00%
!
35.0¢

I am actually suggesting 30x CURRENT earnings (FY2021 NPAT...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.25M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $21.92K | 62.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5714 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5714 | 0.350 |
1 | 355 | 0.345 |
1 | 355 | 0.340 |
2 | 2992 | 0.335 |
2 | 13000 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 5000 | 1 |
0.360 | 159902 | 3 |
0.365 | 85027 | 4 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 11.21am 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online